Markets & Finance

Lower Estimate for Affymetrix

Company: Affymetrix (AFFX)

Year ending: Dec-02

Prior estimate: 0.13

New estimate: 0.07

Rationale: Higher than expected costs

Company: CuraGen Corp. (CRGN)

Year ending: Dec-02

Prior estimate: d1.08

New estimate: d1.78

Rationale: Higher R&D and SG&A costs

Company: Read-Rite (RDRT)

Year ending: Sep-02

Prior estimate: 0.15

New estimate: d0.30

Rationale: Prro prod. transition execution

Company: Ultratech Stepper (UTEK)

Year ending: Dec-02

Prior estimate: d0.06

New estimate: 0.10

Rationale: Reflects end-market improvement

Hollywood Goes YouTube

(enter your email)
(enter up to 5 email addresses, separated by commas)

Max 250 characters

Sponsored Financial Commentaries

Sponsored Links

Buy a link now!

blog comments powered by Disqus